Néovacs organise une réunion KOL concernant son vaccin thérapeutique IFNalpha Kinoïde pour le traitement du lupus - 11 février à Paris
February 05, 2019 01:30 ET
|
NEOVACS
NÉOVACS ORGANISE UNE RÉUNION KOLCONCERNANT SON VACCIN THÉRAPEUTIQUE IFNα KINOÏDEPOUR LE TRAITEMENT DU LUPUS 11 FÉVRIER 2019 – 17h00Hôtel Renaissance Le Parc Trocadéro - Paris Paris et Boston,...
Neovacs to host KOL Meeting to discuss its therapeutic vaccin IFNalpha Kinoid for lupus treatment - February 11th Paris
February 05, 2019 01:30 ET
|
NEOVACS
NEOVACS TO HOST KOL MEETING TO DISCUSS ITS THERAPEUTIC VACCINE IFNα KINOID FOR LUPUS TREATMENT FEBRUARY 11, 2019 – 17h00Hôtel Renaissance Le Parc Trocadéro – Paris Paris and Boston, February...
Néovacs annonce la constitution de son comité clinique en vue de la préparation de la Phase III avec l'IFNalpha Kinoide en Lupus - 11 février à Paris
January 31, 2019 11:45 ET
|
NEOVACS
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS ANNONCE LA CONSTITUTION DE SON COMITÉ CLINIQUE EN VUE DE LA PREPARATION DE LA...
Neovacs announces its clinical advisory board meeting to design the Phase III Study for IFNalpha Kinoide in lupus - Paris February 11th
January 31, 2019 11:45 ET
|
NEOVACS
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS ANNOUNCES ITS CLINICAL ADVISORY BOARD MEETING TO DESIGN THE PHASE III STUDY FOR IFN-K IN LUPUS MEETING TO BE HELD IN PARIS,...
Néovacs présentera les résultats complets de l'étude clinique de Phase IIb avec l'IFNalpha Kinoïde au 13th International Lupus Congress
January 24, 2019 11:45 ET
|
NEOVACS
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE NÉOVACS PRÉSENTERA LES RÉSULTATS COMPLETS DE L’ÉTUDE CLINIQUE DE PHASE IIb AVEC l’IFNα Kinoïde AU 13TH INTERNATIONAL...
Neovacs to present full results from the Phase IIb IFNalpha Kinoid clinical study at the 13th International Lupus Congress
January 24, 2019 11:45 ET
|
NEOVACS
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNalpha KINOID CLINICAL STUDY AT THE 13TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019)5 - 9...
Minor League Baseball and Lupus Foundation of America Partner to Raise Awareness of Lupus Among U.S. Hispanic/Latinx Fans
December 11, 2018 14:00 ET
|
Minor League Baseball
LAS VEGAS, Dec. 11, 2018 (GLOBE NEWSWIRE) -- Minor League Baseball™ (MiLB™) today announced a partnership with the Lupus Foundation of America (LFA) to become an Official Partner of MiLB Copa de la...
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
October 31, 2018 09:42 ET
|
Progentec Diagnostics, Inc.
New funding brings lupus-detection tools closer to commercialization Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Oct. ...
UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
October 23, 2018 01:00 ET
|
Biogen Inc.; UCB
BRUSSELS, Belgium and CAMBRIDGE, Mass., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Today UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) announced top-line results from a Phase 2b study...
Exagen Announces Launch of Novel Biomarker PC4d Associated with Thrombosis in Lupus
October 12, 2018 10:01 ET
|
Exagen Diagnostics, Inc.
ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, a leader in autoimmune life sciences, announced today that it will be updating the popular AVISE® SLE Monitor...